Thanks Pixie! Yes, the early version of Travelan Dr. Tacket studied in a human trial provided 100% protection against ETEC. 9 of the 10 patients given placebo and challenged with a liquid form of ETEC strain developed diarrhea, but 0 out of 10 patients given Dr. Tacket's early version of Travelan and similarly challenged with ETEC developed diarrhea. 0 out 10. 100% protection with P value of .0001. No side effects to drug were reported. An astounding and incredible result published in the New England Journal of Medicine.
The recent DoD Travelan/Shigella challenge on non-human primates (I don't think it would be ethical to do a Shigella/ETEC challenge on humans anymore ...at least....not in the developed world, anyway) provided equally compelling results. There is absolutely no doubt Travelan and IMM-124E work to prevent these terrible bacterial GI pathogenic diseases. The only question that remains is when Immuron can capitalize on it.
- Forums
- ASX - By Stock
- IMC
- Carol Tacket, Travelan, and the New England Journal of Medicine
Carol Tacket, Travelan, and the New England Journal of Medicine, page-8
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMC (ASX) to my watchlist
(20min delay)
|
|||||
Last
10.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $23.93M |
Open | High | Low | Value | Volume |
10.5¢ | 11.0¢ | 10.5¢ | $27.18K | 258.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 320829 | 10.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
10.5¢ | 4965 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 320829 | 0.100 |
2 | 84293 | 0.099 |
1 | 71000 | 0.098 |
2 | 150000 | 0.097 |
1 | 150000 | 0.096 |
Price($) | Vol. | No. |
---|---|---|
0.105 | 4965 | 1 |
0.110 | 232704 | 4 |
0.120 | 208695 | 2 |
0.125 | 223748 | 3 |
0.130 | 173247 | 5 |
Last trade - 15.38pm 27/09/2024 (20 minute delay) ? |
Featured News
IMC (ASX) Chart |